| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/2015 | US8946155 Long-acting polypeptides and methods of producing and administering same |
| 02/03/2015 | US8946154 Peptide ligands of somatostatin receptors |
| 02/03/2015 | US8946153 Fast dissolving pharmaceutical composition |
| 02/03/2015 | US8946152 Method of treating parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen |
| 02/03/2015 | US8946151 Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen |
| 02/03/2015 | US8946150 Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| 02/03/2015 | US8946149 Use of exendin and analogs thereof to delay or prevent cardiac remodeling |
| 02/03/2015 | US8946148 Modified insulin polypeptides and their uses |
| 02/03/2015 | US8946147 Amide-based insulin prodrugs |
| 02/03/2015 | US8946146 Method for modulating appetite |
| 02/03/2015 | US8946145 Modified compstatin with peptide backbone and C-terminal modifications |
| 02/03/2015 | US8946144 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 02/03/2015 | US8946142 Beta-arrestin effectors and compositions and methods of use thereof |
| 02/03/2015 | US8946127 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 02/03/2015 | US8945926 Expanding the eukaryotic genetic code |
| 02/03/2015 | US8945921 Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells |
| 02/03/2015 | US8945901 High activity mutants of butyrylcholinesterase for cocaine hydrolysis |
| 02/03/2015 | US8945895 Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| 02/03/2015 | US8945877 Polynucleotides encoding BMP-ALK3 antagonists |
| 02/03/2015 | US8945869 Factor VIII glycoforms |
| 02/03/2015 | US8945839 CRISPR-Cas systems and methods for altering expression of gene products |
| 02/03/2015 | US8945623 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 02/03/2015 | US8945619 Shell-and-core dosage form approaching zero-order drug release |
| 02/03/2015 | US8945604 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 02/03/2015 | US8945602 Porous photonic crystals for drug delivery to the eye |
| 02/03/2015 | US8945600 Methods of delivering pharmaceutical agents |
| 02/03/2015 | US8945599 Immobilized biologically active entities having a high degree of biological activity |
| 02/03/2015 | US8945591 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 02/03/2015 | US8945589 Immunogenic compositions for Streptococcus agalactiae |
| 02/03/2015 | US8945586 Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin |
| 02/03/2015 | US8945583 GLUT-1 as a receptor for HTLV envelopes and its uses |
| 02/03/2015 | US8945578 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 02/03/2015 | US8945576 Vaccine for treatment of tautopathy |
| 02/03/2015 | US8945575 Treatment of IgE-mediated disease |
| 02/03/2015 | US8945574 Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
| 02/03/2015 | US8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/03/2015 | US8945569 Jagged-binding agents and uses thereof |
| 02/03/2015 | US8945561 Receptor modulators |
| 02/03/2015 | US8945557 Use of immunesuppressant receptor |
| 02/03/2015 | US8945551 Biopolymer hybrid gel-depot delivery system |
| 02/03/2015 | US8945542 Methods for treating lysosomal acid lipase deficiency |
| 02/03/2015 | US8945541 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases |
| 02/03/2015 | US8945540 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof |
| 02/03/2015 | US8945539 Enzyme and prebiotic combinations for enhancing probiotic efficacy |
| 02/03/2015 | US8945537 Process, tube and device for the preparation of wound healant composition |
| 02/03/2015 | US8945532 Anti-aging formulations |
| 02/03/2015 | US8945529 Biphasic lipid-vesicle compositions |
| 02/03/2015 | US8945528 Use of interleukin-22 in treating viral hepatitis |
| 02/03/2015 | US8945511 Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3 |
| 02/03/2015 | CA2768008C Clostridial neurotoxins for treating uterine disorders |
| 02/03/2015 | CA2758976C Chemosensory receptor ligand-based therapies |
| 02/03/2015 | CA2698173C Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 02/03/2015 | CA2695952C Micro-particles, blood-substitute and method for forming same |
| 02/03/2015 | CA2626414C A composition comprising a coupled enzyme system |
| 02/03/2015 | CA2608463C Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers |
| 02/03/2015 | CA2603143C Improved botulinum toxin compositions |
| 02/03/2015 | CA2578573C Use of il-17- for maturation of oocytes |
| 02/03/2015 | CA2465009C Cytotoxin with a subtilase domain |
| 02/03/2015 | CA2463798C Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 02/03/2015 | CA2452593C Triple polypeptide complexes |
| 02/03/2015 | CA2374416C Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/03/2015 | CA2222283C Improved virus vaccines |
| 01/29/2015 | WO2015013690A1 Vasopressin-2 receptor agonists |
| 01/29/2015 | WO2015013669A1 Mps peptides and use thereof |
| 01/29/2015 | WO2015013542A1 Enhanced functionality and delivery of a protein from a porous substrate |
| 01/29/2015 | WO2015013454A1 Methods and compositions comprising desmopressin in combination with a beta-3 adrenergic receptor agonist |
| 01/29/2015 | WO2015013453A1 Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor |
| 01/29/2015 | WO2015013330A2 Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof |
| 01/29/2015 | WO2015013313A2 Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| 01/29/2015 | WO2015013168A1 Cyclic polypeptides for the treatment of heart failure |
| 01/29/2015 | WO2015013167A1 Disulfide cyclic polypeptides for the treatment of heart failure |
| 01/29/2015 | WO2015013165A1 Cyclic apelin derivatives for the treatment of heart failure |
| 01/29/2015 | WO2015012944A1 Methods and compositions for increasing enzyme activity in the cns |
| 01/29/2015 | WO2015012904A2 Antibody-sn-38 immunoconjugates with a cl2a linker |
| 01/29/2015 | WO2015012899A1 Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent |
| 01/29/2015 | WO2015011977A1 Subcutaneous injection preparation for inducing bovine superovulation |
| 01/29/2015 | WO2015011711A1 Short peptides derived from vdac1, compositions and methods of use thereof |
| 01/29/2015 | WO2015011483A1 Domain 5 of cd163 for use in antiviral compositions against prrs, and transgenic animals |
| 01/29/2015 | WO2015011447A1 Therapeutic intervention |
| 01/29/2015 | WO2015011332A1 Polynucleotide containing the gef and apoptin genes, and the use thereof in gene therapy for colon cancer |
| 01/29/2015 | WO2015011293A1 Insect metalloproteinase inhibitors |
| 01/29/2015 | WO2015011254A1 Methods and pharmaceutical compositions for the treatment of bacterial infections |
| 01/29/2015 | WO2015011204A1 Serum for treating diseases |
| 01/29/2015 | WO2015011188A1 Fibroin-based pharmaceutical spray compositions for the treatment of skin lesions |
| 01/29/2015 | WO2015011104A1 Polysaccharide hydrogels for injection with tunable properties |
| 01/29/2015 | WO2015010615A1 Recombinant trail protein and preparation method and use thereof |
| 01/29/2015 | WO2015010210A1 Compounds for regulating acylated ghrelin |
| 01/29/2015 | WO2014201378A9 Synergistic tumor treatment with extended-pk il -2 and adoptive cell therapy |
| 01/29/2015 | US20150031757 Treating glaucoma, cardiovascular diseases, and renal diseases |
| 01/29/2015 | US20150031753 Complexing agents for compositions containing inclusion complexes |
| 01/29/2015 | US20150031731 Polymorph of a pharmaceutical |
| 01/29/2015 | US20150031637 Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| 01/29/2015 | US20150031636 Ibat inhibitors for the treatment of liver diseases |
| 01/29/2015 | US20150031635 Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids |
| 01/29/2015 | US20150031634 Angiotensin peptides in treating marfan syndrome and related disorders |
| 01/29/2015 | US20150031632 Orally Disintegrating Compositions of Linaclotide |
| 01/29/2015 | US20150031631 Pharmaceutical compositions and related methods of delivery |
| 01/29/2015 | US20150031630 Peptide Pharmaceuticals |
| 01/29/2015 | US20150031629 Ophthalmic formulation derived from silk protein |
| 01/29/2015 | US20150031628 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |